Related Experiment Video
Updated: Apr 26, 2026
11:17
Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
Published on: April 3, 2015
11.2K
Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold
Juan Carlos Rama-Merchan1, Alessio Mattesini1, Gianni Dall'Ara1
1Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Harefield Trust, London, United Kingdom.
Abstract:
Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS have not yet been fully tested in complex lesions, including chronic total occlusion (CTO). We report a CTO case successfully treated with a second-generation bioabsorbable drug-eluting scaffold.
